Conference
Intermittent cyclical therapy with etidronate prevents bone loss in corticosteroid treated patients and reduces fracture rate in a subgroup of postmenopausal women.
Authors
Adachi JD; Chines AA; Stephenson GF; Pack S
Volume
12
Pagination
pp. P267-P267
Publisher
BLACKWELL SCIENCE INC
Publication Date
August 1, 1997
Conference proceedings
JOURNAL OF BONE AND MINERAL RESEARCH
ISSN
0884-0431